Renaissance Technologies’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-10,200
| Closed | -$2.03M | – | 3326 |
|
|
2025
Q4 | $2.03M | Buy |
+10,200
| New | +$1.85M | ﹤0.01% | 1854 |
|
|
2022
Q3 | – | Sell |
-78,509
| Closed | -$16.8M | – | 4070 |
|
|
2022
Q2 | $16.8M | Buy |
78,509
+44,100
| +128% | +$10.8M | 0.02% | 821 |
|
|
2022
Q1 | $9.77M | Buy |
34,409
+7,309
| +27% | +$2.25M | 0.01% | 1139 |
|
|
2021
Q4 | $10.2M | Sell |
27,100
-13,200
| -33% | -$5.13M | 0.01% | 1063 |
|
|
2021
Q3 | $16.6M | Sell |
40,300
-16,500
| -29% | -$6.85M | 0.02% | 762 |
|
|
2021
Q2 | $21M | Sell |
56,800
-123,389
| -68% | -$41.2M | 0.03% | 735 |
|
|
2021
Q1 | $52.2M | Sell |
180,189
-254,300
| -59% | -$70.7M | 0.07% | 337 |
|
|
2020
Q4 | $109M | Sell |
434,489
-283,190
| -39% | -$67.4M | 0.12% | 169 |
|
|
2020
Q3 | $163M | Sell |
717,679
-317,100
| -31% | -$65.8M | 0.16% | 116 |
|
|
2020
Q2 | $180M | Sell |
1,034,779
-302,609
| -23% | -$48.3M | 0.16% | 127 |
|
|
2020
Q1 | $169M | Sell |
1,337,388
-90,191
| -6% | -$13.5M | 0.16% | 127 |
|
|
2019
Q4 | $218M | Sell |
1,427,579
-29,104
| -2% | -$4.03M | 0.17% | 127 |
|
|
2019
Q3 | $193M | Sell |
1,456,683
-207,817
| -12% | -$27.9M | 0.16% | 124 |
|
|
2019
Q2 | $236M | Sell |
1,664,500
-221,200
| -12% | -$30M | 0.21% | 101 |
|
|
2019
Q1 | $274M | Buy |
1,885,700
+8,591
| +0.5% | +$1.13M | 0.25% | 76 |
|
|
2018
Q4 | $212M | Buy |
1,877,109
+152,309
| +9% | +$19.1M | 0.23% | 80 |
|
|
2018
Q3 | $232M | Buy |
1,724,800
+209,500
| +14% | +$25.9M | 0.24% | 78 |
|
|
2018
Q2 | $170M | Buy |
1,515,300
+55,000
| +4% | +$5.95M | 0.19% | 105 |
|
|
2018
Q1 | $156M | Buy |
1,460,300
+61,600
| +4% | +$6.64M | 0.17% | 109 |
|
|
2017
Q4 | $153M | Buy |
1,398,700
+58,991
| +4% | +$6.42M | 0.17% | 114 |
|
|
2017
Q3 | $145M | Buy |
1,339,709
+119,826
| +10% | +$12.3M | 0.17% | 119 |
|
|
2017
Q2 | $123M | Buy |
1,219,883
+153,374
| +14% | +$14.1M | 0.16% | 128 |
|
|
2017
Q1 | $95.9M | Sell |
1,066,509
-53,700
| -5% | -$4.56M | 0.13% | 157 |
|
|
2016
Q4 | $85.3M | Buy |
1,120,209
+184,300
| +20% | +$14M | 0.14% | 158 |
|
|
2016
Q3 | $78M | Buy |
935,909
+155,800
| +20% | +$13.1M | 0.14% | 153 |
|
|
2016
Q2 | $64.3M | Sell |
780,109
-170,100
| -18% | -$14M | 0.12% | 173 |
|
|
2016
Q1 | $72.2M | Buy |
950,209
+77,700
| +9% | +$5.75M | 0.14% | 141 |
|
|
2015
Q4 | $70.1M | Buy |
872,509
+56,300
| +7% | +$4.06M | 0.15% | 119 |
|
|
2015
Q3 | $51.8M | Sell |
816,209
-266,400
| -25% | -$19.1M | 0.12% | 158 |
|
|
2015
Q2 | $76.2M | Buy |
1,082,609
+253,277
| +31% | +$18.7M | 0.17% | 98 |
|
|
2015
Q1 | $65.8M | Buy |
829,332
+416,723
| +101% | +$30.7M | 0.14% | 136 |
|
|
2014
Q4 | $26.3M | Buy |
412,609
+53,800
| +15% | +$3.37M | 0.06% | 377 |
|
|
2014
Q3 | $21.4M | Buy |
358,809
+25,700
| +8% | +$1.47M | 0.06% | 421 |
|
|
2014
Q2 | $17.8M | Sell |
333,109
-468,309
| -58% | -$25.7M | 0.04% | 538 |
|
|
2014
Q1 | $48.4M | Buy |
801,418
+134,709
| +20% | +$7.85M | 0.12% | 181 |
|
|
2013
Q4 | $35.4M | Sell |
666,709
-239,500
| -26% | -$12M | 0.08% | 276 |
|
|
2013
Q3 | $41.9M | Sell |
906,209
-278,100
| -23% | -$12.8M | 0.1% | 219 |
|
|
2013
Q2 | $48.6M | Buy |
+1,184,309
| New | +$50.7M | 0.13% | 188 |
|
Other funds holding CRL
VCM
VPM
Renaissance Technologies's CRL Position: Q1 2026 in Review
Renaissance Technologies sold out of Charles River Laboratories (CRL) in Q1 2026, closing a stake of 10,200 shares — an estimated $2.03M sold.
Renaissance Technologies first reported a position in CRL in Q2 2013 and held it in 38 quarters. The position peaked at $274M in Q1 2019. 557 funds tracked by Wall St. Rank hold CRL as of Q1 2026.
- Renaissance Technologies reported no remaining Charles River Laboratories position as of Q1 2026 after selling out during the quarter.
- Renaissance Technologies sold 10,200 Charles River Laboratories shares in Q1 2026, an estimated $2.03M.
- Renaissance Technologies first reported a position in Charles River Laboratories in Q2 2013 and held it in 38 quarters.
- Renaissance Technologies's Charles River Laboratories position peaked at $274M in Q1 2019.
- 557 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2026.
Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.